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Commentaries

A little stress is good:
IFN-γ, demyelination, and multiple sclerosis
Jason R. Lees1 and Anne H. Cross2,3
1Department

3Hope

of Molecular Biology and Pharmacology, 2Department of Neurology and Neurosurgery, and
Center for Neurological Disorders, Washington University School of Medicine, St. Louis, Missouri, USA.

The exact role(s) of the cytokine IFN-γ in the demyelinating disease multiple
sclerosis remain controversial, with evidence suggesting both detrimental
and protective effects of the cytokine in MS and MS models such as EAE.
The study by Lin and coworkers in this issue of the JCI produces evidence
that protective effects of IFN-γ on mature oligodendrocytes during EAE
induction are mediated via activation of the pancreatic ER kinase (PERK),
resulting in induction of the endoplasmic reticular stress response pathway
(see the related article beginning on page 448). Modulation of this stress
pathway has what we believe to be novel therapeutic potential for MS.
MS is a debilitating chronic disease of the
CNS that affects over 400,000 people in the
United States. MS is marked by infiltration
of the CNS by inflammatory cells and by
destruction of oligodendrocytes (ODCs)
and the associated myelin sheaths within
CNS white matter (1). The amount of ODC
loss in MS is variable and appears to evolve
into 2 major patterns in active lesions (2).
One type is characterized by extensive ODC
destruction. Although oligodendroglial
precursor cells are often present, these cells
are not associated with significant remyelination. Preservation of ODCs, allowing the
possibility of remyelination, would be highly
beneficial to these patients. In contrast, the
second lesion type is characterized by ODC
survival and ODC progenitor recruitment,
often with significant remyelination (2).
IFN-γ is a major cytokine found in MS
lesions, and its levels are greatly increased
during MS activity. Inflammation in both
MS and EAE is associated with an IFN-γ–
producing Th1 response (3, 4). In rodent
MS models, skewing of the cytokine milieu
away from a Th1 lineage and toward a Th2producing response clearly ameliorates
EAE (5, 6). Administration of IFN-γ to
people with MS aggravates clinical disease,
resulting in increased numbers of relapses
in patients (7). However, several studies
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Conflict of interest: The authors have declared that no
conflict of interest exists.
Citation for this article: J. Clin. Invest. 117:297–299
(2007). doi:10.1172/JCI31254.

have suggested that IFN-γ may actually
have a beneficial role in EAE and other
demyelinating animal models. Induction
of EAE in mice lacking IFN-γ or the IFN-γ
receptor as well as administration of anti–
IFN-γ antibodies all have resulted in more
severe disease, suggesting that IFN-γ may
limit disease (8–10). Results from studies
using the ODC toxin cuprizone indicated
that IFN-γ treatment of ODCs might render them less susceptible to the toxin (11).
Because of the prominent role of IFN-γ
in the development of an autoimmune
response, several immunomodulatory
functions of IFN-γ have been suggested
as potential disease-altering mechanisms.
These mechanisms range from affecting the
initiation of the T cell anti-CNS response,
to induction of apoptosis in CNS-infiltrating leukocytes, to repression of the induction of IL-17–producing encephalitogenic
T cells (8–10, 12).
Enhancing ODC survival
In this issue of the JCI, Lin, Popko, and colleagues have provided compelling evidence
of an unexpected mechanism by which IFN-γ
could prove beneficial: a direct protective
effect on mature ODC survival during EAE
in mice (13). Using CNS-specific IFN-γ production regulated by tetracycline-repressed
control of a glial fibrillary acidic protein
(GFAP) promoter, the authors examined
the effect of early IFN-γ production confined to the CNS on subsequent EAE. By
means of this temporally restricted expression of IFN-γ production by astrocytes, the
effects of CNS-specific IFN-γ production on
EAE induction in an otherwise developmen-
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tally normal system were examined. ODC
survival was significantly enhanced upon
IFN-γ expression in the CNS following EAE
induction. The survival of ODCs was associated with a reduced disease course and
less demyelination. No association of this
protective effect and the effects of IFN-g on
the immune system was apparent. Indeed,
the production of CNS IFN-γ had surprisingly little effect on microglia and invading
macrophages at any time reported, nor did
it involve regulation of initial immune cell
entry or cytokine production (13).
A role for the ER
Several groups have previously suggested
a role for ER stress–induced cell death in
the initiation of autoimmune and neurodegenerative diseases (14, 15). Induction
of ER stress has also been shown to result
in reduction of protein synthesis and concomitant protection of cells from future
stress (16, 17). This cytoprotective pathway has been called the integrated stress
response and relies on activation of the
pancreatic ER kinase (PERK). As IFN-γ is
known to induce PERK activation, Lin et al.
(13) assessed the capacity of CNS-specific
delivery of IFN-γ to induce the integrated
stress response. Induction of CNS-specific
IFN-γ resulted in activation of the integrated stress response initiated by PERK activation followed by phosphorylation of the α
subunit of the eukaryotic translation initiation factor 2 (eIF2α). Support for a critical
role for PERK induction of the integrated
stress response in ODC protection was
found when PERK deficiency abrogated
the protective effects of IFN-γ.
The present findings by Lin et al. (13) are
in contrast to previous reports that the ER
stress response induces apoptosis in newly
developed ODCs responsible for remyelination following demyelination (18). This
same group of investigators has previously shown that IFN-γ induced ER stress in
myelinating ODCs during development
or remyelination, which led to ODC death
and myelin abnormalities, while PERK
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Figure 1
A model of the differential responses to IFN-γ
of ODCs during their differentiation. The schematic shows the response of ODCs, at 2 different stages of development, to IFN-γ delivered to the CNS before EAE onset in mice.
Low constitutive protein production allows
mature ODCs (top left) to survive the increase
in ER stress that is associated with the initial
interaction with IFN-γ (bottom left). Having
survived the original stressor, mature ODCs
induce activation of PERK. PERK activation
in turn induces eIF2α phosphorylation, ultimately allowing ODCs to acquire resistance
to further ER stress. The acquired resistance
to ER stress protects cells from apoptotic
mechanisms associated with EAE, allowing
the cells to maintain functional myelin sheaths
and concomitantly reducing clinical symptoms
observed in MS. In contrast, a high level of
constitutive protein production in developing
ODCs (top right) results in toxic levels of ER
stress following IFN-γ treatment (bottom right),
resulting in an increased risk of apoptosis in
developing ODCs.

activation provided some small degree of
protection from these effects (18, 19). The
increased IFN-γ–induced death of remyelinating ODCs in PERK-deficient mice
observed in the earlier studies was reiterated in the current paper (13) by the apparent increase in cellular damage associated
with IFN-γ treatment of PERK-deficient
mice (see Figure 2, A and C, in ref. 13) as
well as the slightly higher death rate even
in the absence of CNS-specific IFN-γ (see
Table 1 in ref. 13).
Understanding the conflicting
actions of IFN-γ in demyelination
How does one resolve these conflicting
reports? Lin et al. (13) speculate that the
differences observed relate to the timing of
IFN-γ administration and to the differential effects of ER stress induced by IFN-γ on
actively myelinating ODCs versus mature
ODCs, suggesting a model in which the
response to IFN-γ by a given cell would be
directly related to its relative rate of protein
production. IFN-γ–induced protein expression (of molecules such as MHC class I)
would represent the final push necessary
to convert a protective, modest level of ER
298

stress response in remyelinating ODCs
actively involved in high-level protein production to a destructive, severe ER stress
response. In contrast, protein expression
induced by IFN-γ would only be sufficient
to drive mature ODCs, with their lower
baseline protein production, to a modest level of ER stress, with a concomitant
PERK-induced protective stress response.
Thus, in mature ODCs functioning only
to maintain myelin made at a prior time,
the integrated stress response would be
protective. In contrast, actively remyelinating ODCs would have increased sensitivity
to the additional ER stress associated with
IFN-γ–induced protein expression resulting in ODC cell destruction (Figure 1).
The possibility that the IFN-γ response is
different for different stages of ODC differentiation fits well with many of Popko and
colleagues’ previous findings regarding the
involvement of PERK (18, 19). Further dissection of the paradigm reported here (13)
would also be interesting with regard to the
role of ODC death in the recruitment of
T cells in the EAE model of disease and its
implications for human MS. This paradigm
may provide an opportunity to differentiate
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what aspects of pathophysiology are directly caused by ODC death and what aspects
are regulated by inflammatory mechanisms
independent of demyelination.
Together, the data discussed here indicate that the regulation of the balance of
cell stress is likely to play a vital role in the
response of ODCs to the highly complex
pathologic mechanisms involved in demyelinating disease. To compound the complexity of the situation, the role of ODC
death in human MS may vary from patient
to patient. Some patients may have a type
of MS in which ODC precursors are critical
for remyelination. Based upon these animal
models, IFN-γ would be detrimental in that
situation. On the other hand, those people
with MS characterized predominantly
by ODC death might benefit from IFN-γ
delivered to the CNS at the proper time.
CNS-specific IFN-γ expression has been
variably reported as increased, decreased, or
unchanged in MS patients. It would be of
considerable interest to correlate the level
of CNS-specific IFN-γ and the degree of
IFN-γ–induced integrated stress response
with the predominant pathology of ODCs
in individuals affected with MS. Indeed,
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an understanding of these relationships
would be required before attempting to
alter ODC stress responses in MS patients
for therapeutic benefit.
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Notch: a mastermind of vascular morphogenesis
Leonard M. Anderson and Gary H. Gibbons
Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, Georgia, USA.

The way in which multiple cell types organize themselves into a carefully
sculpted, 3D labyrinth of vessels that regulate blood flow throughout the
body has been a longstanding mystery. Clinicians familiar with congenital
cardiovascular disease recognize how genetic variants and modest perturbations in this complex set of spatiotemporal interactions and stochastic processes can result in life-threatening anomalies. Although the mystery is not
yet fully solved, we are poised at an exciting juncture, as insights from murine
disease models are converging with advances in human genetics to shed new
light on puzzling clinical phenotypes of vascular disease. The study by High
et al. in this issue of the JCI establishes a model system that mimics clinical
features of congenital cardiovascular disease and further defines the role of
the Notch signaling pathway in the neural crest as an essential determinant of
cardiovascular structure (see the related article beginning on page 353).
The process of vascular
morphogenesis
In the embryo, endothelial precursors initially assemble into a primitive plexus of
channels that expand by sprouting and
Nonstandard abbreviations used: HERP, HES-related
repressor protein; HES, hairy and enhancer of split;
MAML, mastermind-like; Tbx1, T-box 1.
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remodeling into a highly organized arborization of vessels that ramify throughout
the body. Studies in various knockout
mouse models suggest that VEGF, angiopoietins, and PDGF provide local cues
that promote vascular morphogenesis
and the investment of the endothelial
channels with a VSMC layer. The architecture of the vascular tree is further refined
to very precise dimensions in accordance
with biomechanical parameters of shear
and radial stresses (1, 2).
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In a classic series of seminal studies
involving quail-chick chimeras and tissue
ablation experiments, Kirby and colleagues
established that the cardiac neural crest
plays an essential role in establishing the
pattern of the vertebrate vascular system
(3). The molecular mechanisms underlying
these phenomena are gradually being elucidated (Table 1). The cardiac neural crest
(an ectodermal cell population arising from
the dorsal neural tube) migrates to populate the aortic arch arteries and cardiac outflow tract. The migrating cardiac neural
crest cells contribute to the septation of the
truncus arteriosus into a separate pulmonary artery and aorta. Similarly, a subpopulation of these neural crest cells becomes
part of the mass of VSMCs that contribute
to the formation of the pulmonary trunk,
ductus arteriosus, carotid arteries, and
proximal subclavian arteries (3–5). The
study reported by High et al. in this issue of
the JCI (6) provides the first demonstration
to our knowledge that the Notch transcriptional cascade within the neural crest plays
an essential mediator role in VSMC differ-
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